East Windsor, NJ (October 26, 2016) – Sabinsa’s Curcumin C3 Complex® has been found by researchers in several studies to be an excellent complementary supplement to Omega-‐3 fatty acids. While curcumin is a well-‐recognized anti-‐inflammatory agent, Omega-‐3 acids are known precursors of several biosynthetic inflammatory resolvers. Together C3 Complex® and Omega-‐3 acids work in tandem to bring about relief under situations where inflammation can cause damage.
Use of this combination has been studied by researchers over several years:
• As early as 2009, it was found that C3 Complex attenuates muscle wasting (cachexia) that usually accompanies certain disease conditions [British J Nutrition (2009) 102, 967-‐975].
• Recent mechanistic studies revealed that the synergistic effect of C3 Complex® and Eicosapentaenoic acid, an Omega3 component, against the depredations caused by both TNF-‐α and PIF (Proteolysis-‐inducing Factor) by ameliorating protein synthesis and halting protein degradation. [In Vitro Cell. Dev. Biol. DOI 10.1007/s11626-‐016-‐0051-‐z]
• Animal experiments presented in Experimental Biology Meeting 2016, San Diego showed a clear synergy in action in reducing cancer cachexia in MAC-‐16 colon tumor-‐bearing mice. This combination Omega-‐3 EPA and C3 Complex is expected to attenuate weight loss caused by health conditions, and improve quality of life. [Abstract published in The FASEB Journal 30(1) supplement lb312]
“Curcumin and Omega 3’s have become staples of many consumer’s dietary supplement regimen in recent years, making it beneficial to know how the combination of the two work together,” said Shaheen Majeed, Sabinsa Marketing Director. “While these results are exciting, they apply to C3 Complex only. We can’t speculate that the same benefits would be found with other brands of Curcumin, given the many very different forms on the market.”
About Sabinsa Corporation:
Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-‐being. Over the past 28 years, Sabinsa has brought to market more than 100 standardized botanical extracts, and privately funded clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 full-‐time scientists conducting ongoing research in India and the United States, Sabinsa and parent company Sami Labs Ltd. continue to develop, patent and manufacture phytonutrients for the world market, with ingredients that are both Halal and Kosher. For more information, visit www.sabinsa.com.
